Digital Pathology Market Summary

The global digital pathology market size was valued at USD 1.39 billion in 2024 and is expected to reach USD 2.97 billion by 2033, growing at a CAGR of 8.6% from 2025 to 2033. This growth is primarily driven by the rising prevalence of cancer, an increasing emphasis on improving laboratory workflow efficiency, and the growing demand for faster and more accurate diagnostic tools. Digital pathology enables the conversion of traditional glass slides into high-resolution digital images, allowing pathologists to analyze samples more efficiently and collaborate remotely, thereby supporting market expansion.

Additionally, rising investments in the healthcare sector, supported by major key players focusing on new product launches and technological advancements, are accelerating market growth. The increasing adoption of telepathology is further enhancing access to expert diagnostic services, particularly in remote and underserved regions. Furthermore, the growing focus on drug discovery and precision medicine is boosting demand for digital pathology solutions, as these tools enable detailed tissue analysis, biomarker identification, and data integration to support targeted treatment development.

The industry is largely driven by the growing prevalence of chronic diseases, particularly cancer. Due to the high incidence of cancer globally, pathologists require advanced pathology data to support the customization of therapies for individual patients. Digital pathology is increasingly preferred as it accelerates diagnostic processes, improves accuracy, and supports therapeutic decision-making. By enabling quantitative analysis and data sharing, digital pathology contributes to improved patient outcomes and more personalized care.

Key Market Trends & Insights

• North America dominated the global digital pathology market in 2024 with a share of 40.10%, supported by advanced healthcare infrastructure, high adoption of digital technologies, and strong research activities.
• The digital pathology market in Asia Pacific is expected to grow at the fastest CAGR from 2025 to 2033, driven by expanding healthcare infrastructure, rising cancer incidence, and increasing adoption of digital healthcare solutions.
• By type, the human pathology segment held the largest share of 89.92% in 2024, reflecting extensive use in clinical diagnostics and research.
• By product, the software segment held the largest share of 43.86% in 2024, driven by demand for image management, analysis, and artificial intelligence-based tools.
• By application, the academic research segment dominated the market in 2024 with the largest share, as digital pathology supports advanced research and educational initiatives.

Order a free sample PDF of the Digital Pathology Market Intelligence Study, published by Grand View Research.

Market Size & Forecast

• 2024 Market Size: USD 1.39 Billion
• 2033 Projected Market Size: USD 2.97 Billion
• CAGR (2025-2033): 8.6%
• North America: Largest market in 2024

Key Companies & Market Share Insights

Key players operating in the digital pathology market are undertaking various initiatives to strengthen their presence and increase the reach of their products and services. Strategies such as expansion activities and partnerships are key in propelling the market growth.

Key Players

• Leica Biosystems Nussloch GmbH (Danaher)
• Hamamatsu Photonics, Inc.
• Koninklijke Philips N.V.
• Olympus Corporation
• Hoffmann-La Roche Ltd.
• Mikroscan Technologies, Inc.
• Epredia (3DHISTECH Ltd.)
• Visiopharm A/S
• Huron Technologies International Inc.
• ContextVision AB
• HANGZHOU ZHIWEI INFORMATION TECHNOLOGY CO. LTD. (MORPHOGO)
• West Medica Produktions- und Handels- GmbH (West Medica)
• aetherAI
• IBEX (IBEX MEDICAL ANALYTICS)
• SigTuple Technologies Private Limited
• Morphle Labs, Inc
• Bionovation Biotech, Inc.
• Inspirata, Inc
• Scopio labs
• Path Hub
• Sectra AB
• Agfa-Gevaert Group
• OptraScan
• Agilent Technologies, Inc.
• KFBIO
• CellaVision

Explore Horizon Databook – The world's most expansive market intelligence platform developed by Grand View Research.

Conclusion

The digital pathology market is set for steady growth as healthcare systems increasingly adopt digital solutions to enhance diagnostic accuracy and efficiency. Rising cancer prevalence, expanding telepathology use, and growing focus on precision medicine are key growth drivers. North America continues to lead due to technological maturity, while Asia Pacific shows strong growth potential. With human pathology, software solutions, and academic research driving adoption, digital pathology will play a vital role in advancing diagnostics, research, and personalized healthcare worldwide.